Matrix metalloproteinase - Candidate for clinical joint destruction marker in arthropathy

Connective Tissue

Volumn 33, Issue 1, 2001, Pages 43-49

  Ishiguro, N ^a   Kojima, T ^a   Ito, T ^a   Iwata, H ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arthropathy; Joint marker; Matrix metalloproteinase; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

AGGRECANASE; COLLAGENASE; EPITOPE; GELATINASE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; PROTEINASE;

ARTHROPATHY; CARTILAGE CELL; CARTILAGE DEGENERATION; DISEASE SEVERITY; HUMAN; INFLAMMATORY CELL; OSTEOARTHRITIS; PATHOGENESIS; PROTEIN DEGRADATION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

EID: 0035062115     PISSN: 0916572X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Biochemical mechanisms of articular destruction
2. Rheumatoid arthritis: Pathophysiology and implications for therapy
3. A metalloproteinase disintegrin that releases tumornecrosi factor-alfa from cells
4. Cloning and characterization of ADAMTS 11, an aggrecanase from ADAMTS family
5. Purification of a metalloproteinase inhibitor from human rheumatoid synovial fluid
6. Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, cartilage, and muscle, and is located on mouse chromosome 10
7. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?
8. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity
9. Human MT 6-matrix metalloproteinase: Identification, progelatinase A activation, and expression in brain tumors
10. A matrix metalloproteinase expressed on the surface of invasive tumor cells
11. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in rheumatoid aynovium
12. Differential expression pattern of membrane-type matrix metallotroteinases in rheumatoid arthritis
13. Increased serum proMMP-3 in inflammatory arthritis: A potential indicator of synovial inflammatory monokine activity
14. Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis
15. Determination of Stromelysin-1 (MMP-3), 72 kDa and 92 kDa Type IV collagenase (MMP-2, 9), Tissue Inhibitor of Metalloproteinases-1 (TIMP-1), and TIMP-2 in Synovial Fluid and Serum from Patients with Rheumatoid Arthritis
16. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): Correlation with rheumatoid arthritis
17. Selective enchancement of collagenase-mediated cleavage of resident type II collagen in cultures osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (Matrix metalloproteinase 1)
18. Sites of aggrecan cleavage by recombinant human aggrecanse-1 (ADAMTS-4)
19. Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase 1
20. Cloning, Expression, and Type II Collagenolytic activity of Matrix Metalloproteinase-13 from human osteoarthritic Cartilage
21. Somatic matations in the p 53 tumor supressor gene in rheumatoid arthritis synovium
22. Wild type and mutant p 53 differentially regulate the gene expression of human collagenase-3 (hMMP-13)
23. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase
24. An introduction to the pathophysiology of osteoarthritis
25. Rabbit models of arthritis: Immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage
26. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts 1
27. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation
28. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis
29. Relationship of matrix metalloproteinase and their inhibitors to cartilage proteoglycan and collagen turnover
30. Chondrocyte matrix metalloproteinase-8: Up-regulation on neutrophil collagenase by interleukin-1 b in human cartilage from knee and ankle joints
31. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid